Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350 - Investorplace.com

1. Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350  Investorplace.com
2. Coronavirus vaccine: 'Any vaccine that is available to you, you should take,' says physician  Yahoo Finance
3. Johnson & Johnson vaccine: Virologist explains the good news | Covid-19  The Telegraph
4. Johnson & Johnson's Covid-19 Vaccine Is Good, Despite Lower Efficacy  Bloomberg
5. Covid-19: Novavax vaccine shows 89% efficacy in UK trials  BBC News
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3taFe3C